Clinuvel Pharmaceuticals Market Cap

Clinuvel Pharmaceuticals has a market cap or net worth of $365.91 million as of May 6, 2025. Its market cap has decreased by -20.38% in one year.

Market Cap

365.91M

Enterprise Value

238.02M

Revenue

56.33M

Ranking

n/a

PE Ratio

15.25

Stock Price

$6.95

Market Cap Chart

Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 2.79M to 365.91M, an increase of 13,020.02%. That is a compound annual growth rate of 22.29%.

Market Cap History

Date	Market Cap	% Change
May 5, 2025	367.53M	-1.41%
Dec 31, 2024	372.77M	-31.82%
Dec 29, 2023	546.72M	-24.87%
Dec 30, 2022	727.74M	-25.56%
Dec 31, 2021	977.57M	14.90%
Dec 31, 2020	850.82M	-13.85%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.62B
Nika Pharmaceuticals	1.02B
Veradigm	746.57M
Tian'an Technology Group	546.22M
Glass House Brands	529.49M
Elite Pharmaceuticals	452.95M
Northwest Biotherapeutics	429.16M
CytoDyn	401.57M

Market Cap Rankings